“abraxane” Archives

in
Entry Author Date Location
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results 04/03/19 National
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
Acetylon Crafts New Buyout Deal With Celgene, Spins Out Startup Regenacy 12/02/16 Boston
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out 08/08/16 Boston
West Coast Biotech Roundup: Bock, Celladon, Arivale, Conkwest & More 06/26/15 San Diego
East Coast Biotech Roundup: NJ Blues, Genzyme, Amicus, Biogen & More 08/25/14 Boston
Merrimack Heads to FDA as Pancreatic Cancer Drug Succeeds in Phase 3 05/01/14 Boston
Brushing Off Clinical Setback, Cerulean Tees Up $75M IPO 03/10/14 Boston
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More 01/10/14 Boston
East Coast Life Sciences Roundup: Genocea, Biogen, OvaScience, & More 09/13/13 Boston
Investors to Get $300M as FDA Approves Celgene Drug For Pancreatic Cancer 09/06/13 New York
Cerulean Pharma Arrives at Turning Point With Cancer Drug 03/06/13 Boston
Page 1 of 1

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Carbonite
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.